Results 241 to 250 of about 114,887 (311)

Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda. [PDF]

BMC Cancer
Nakigozi H, Ndejjo R, Bazeyo W, Nabaggala A, Achola C, Iga M, Kalyesubula S, Kanamwangi B, Mutungi G, Batte C, Mukunya D, Sserwanga L, Gemageine G, Oyoo CA, Nabadda S.   +14 more
europepmc   +1 more source

Human papillomavirus‐associated adenoma of the anorectum

Histopathology, Volume 88, Issue 7, Page 1459-1463, June 2026.
Aims Human papillomavirus (HPV) is the most common sexually transmitted disease in the United States. HPV‐associated invasive anorectal adenocarcinoma has been previously described. In this study, we report the clinicopathological features of three HPV‐associated anorectal adenomas.
Paula Toro, Clifton Fulmer, Erica Savage, Xuefeng Zhang   +3 more
wiley   +1 more source

Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program

International Journal of Cancer, Volume 158, Issue 10, Page 2729-2735, 15 May 2026.
What's New? The strategy to offer self‐sampling for human papillomavirus testing to increase cervical cancer screening attendance among long‐term non‐attenders has been mostly validated in randomized trials. This real‐life implementation of self‐sampling for long‐term non‐attenders to the routine screening program in the capital region of Sweden ...
K. Miriam Elfström, Maria Hortlund, Daniel Öhman, Joakim Dillner   +3 more
wiley   +1 more source

A Systematic Review and Meta‐Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Tumour mutation burden (TMB) is an emerging pan‐cancer biomarker with predictive value for immune checkpoint inhibitor (ICI) outcomes, yet evidence is inconsistent due to methodological variability and cut‐off thresholds. This systematic review and meta‐analysis evaluated the impact of TMB on overall survival (OS) and progression ...
Aijia Meng, Alexander Yuile, Hao‐Wen Sim, Subotheni Thavaneswaran, Humaira Noor, Jacky Yeung, Ashish Mehta, Joseph Powell, Ashraf Zaman   +8 more
wiley   +1 more source

Application of Metagenomic Next‐Generation Sequencing in the Diagnosis of Pneumonia in Patients With Cancer

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background With the development of new sequencing technologies, metagenomic next‐generation sequencing (mNGS) has become a diagnostic tool for respiratory tract infections. Patients with cancer may develop pneumonia caused by infections or antitumor therapy.
Rong Qin, Chao Wang, Minghua Cong, Le Tian, Ning Li   +4 more
wiley   +1 more source

Pap testing and high‐risk HPV testing for women aged 65 years and older with surgical pathology follow‐up

Cancer Cytopathology, Volume 134, Issue 5, May 2026.
ABSTRACT Background Current professional guidelines recommend discontinuing Papanicolaou (Pap) test screening in women aged 65 years and older who have had adequate prior negative testing. However, limited data exist on Pap test performance and histologic outcomes in this population.
Timothy G. Ramseyer, Bethany Batson, Daisy Wu, Jonee L. Matsko, Amy K. Colaizzi, Samer N. Khader, Chengquan Zhao   +6 more
wiley   +1 more source

Clinical Significance of Biomarkers in Oropharyngeal Squamous Cell Carcinoma: Recurrence Prediction and Treatment Response

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence largely driven by human papillomavirus (HPV) infection. Despite advances in multimodal treatment, disease recurrence remains common and limits long‐term survival, highlighting the need for reliable ...
Yunxia Chen, Wenyu Zhang, Xiang Gao, Kongling Xing, Yijing Ren, Jinyu Hu, Zhihao Xie, Ping Zhou   +7 more
wiley   +1 more source

Computational Design of an mRNA Vaccine Targeting LRP6 for Triple‐Negative Breast Cancer Therapy

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Triple‐negative breast cancer (TNBC) presents a poorer prognosis than other breast cancer subtypes, attributed to its aggressive nature and the lack of specific therapeutic interventions. TNBC has high recurrence rates and limited survival despite current therapies, emphasizing the critical need for improved treatment options.
Pooriya Teimoori, Mohammadreza Heidari
wiley   +1 more source

Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background Cervical cancer remains a significant global health challenge, with squamous cell carcinoma (SCC) and adenocarcinoma representing its predominant histologic types. Programmed death‐ligand 1 (PD‐L1) expression in cervical cancer has been implicated in tumor immune evasion, yet its prognostic significance remains unclear.
Zahra Vahedpoor, Amirhasan Matini, Habibollah Rahimi, Majid Lotfinia, Hossein Motedayyen, Leyla Sadat Hejazi   +5 more
wiley   +1 more source

Indicators to identify cancer screening providers with suboptimal case detection: A scoping review

International Journal of Cancer, Volume 158, Issue 9, Page 2339-2358, 1 May 2026.
What's new? Quality control of cancer screening programs is essential to maintaining high public health standards. Here, the authors reviewed monitoring of case detection in cervical and colorectal cancer screening programs in Europe, and evaluated its effectiveness. They analysed 20 different measures used for this purpose and showed that many of them
Jiayao Lei, Milena Falcaro, Adam R. Brentnall, James F. O'Mahony, Sisse Helle Njor, Matejka Rebolj   +5 more
wiley   +1 more source